MPR Weekly Dose 134 — Vaccine Boosters Authorized; Wearable Furosemide System Approved; Molnupiravir Data; Pertussis Vaccine; FDA Apomorphine Device Update

<p><span style="font-weight: 400;">Bivalent COVID-19 booster vaccines for children; wearable device to help treat fluid overload in adults with chronic heart failure; real-world data insights into molnupiravir efficacy; vaccine for the third trimester of pregnancy to prevent pertussis; and an FDA update on apomorphine infusion in Parkinson disease. </span></p>